1. Home
  2. PSQH vs KYNB Comparison

PSQH vs KYNB Comparison

Compare PSQH & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PSQ Holdings Inc.

PSQH

PSQ Holdings Inc.

N/A

Current Price

$6.34

Market Cap

29.3M

ML Signal

N/A

KYNB

Kyntra Bio Inc. Common Stock

N/A

Current Price

$8.11

Market Cap

27.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PSQH
KYNB
Founded
2021
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.3M
27.1M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
PSQH
KYNB
Price
$6.34
$8.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
534.5K
12.5K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
55.00
9552.08
EPS
N/A
N/A
Revenue
$5,685,987.00
$6,440,000.00
Revenue This Year
$80.20
N/A
Revenue Next Year
$34.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1096.61
N/A
52 Week Low
$0.36
$6.32
52 Week High
$6.94
$9.58

Technical Indicators

Market Signals
Indicator
PSQH
KYNB
Relative Strength Index (RSI) 74.78 71.71
Support Level $0.61 $6.61
Resistance Level N/A $8.99
Average True Range (ATR) 0.64 0.31
MACD 0.19 0.13
Stochastic Oscillator 94.85 99.24

Price Performance

Historical Comparison
PSQH
KYNB

About PSQH PSQ Holdings Inc.

PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Share on Social Networks: